On Tuesday, the Ministry of Health and Family Welfare issued a statement dismissing media reports on the scarcity of essential drugs (Clofazimine, Linezolid, Cycloserine) as ‘vague and ill-informed.
Researchers reported on the treatment of rifampin-resistant tuberculosis in the United States using the FDA approved bedaquiline, pretomanid, and linezolid (BPaL) therapy.